What is a 17 Panel Drug Test?
The 17 panel drug test is a urine-based testing solution designed to detect the presence of seventeen drugs or their metabolites in a single sample. This all-in-one test is widely used in clinical, correctional, and workplace testing environments due to its ability to provide fast, reliable, and comprehensive results.
By combining multiple screening capabilities into one device, these cups make drug testing more manageable and cost-effective for facilities.
What Does the 17 Panel Drug Test Detect?
A standout feature of the 17 panel drug test is its capacity to screen for a wide range of substances that are commonly abused.
Amphetamines (AMP), Barbiturates (BAR), Benzodiazepines (BZO), Buprenorphine (BUP), Cocaine (COC), Methamphetamines (MET), Opioids (OPI), Oxycodone (OXY), THC (Marijuana), Fentanyl (FEN), Ethyl-glucuronide (EtG), Gabapentin (GAB), Kratom (KRA), Ketamine (KET), Tricyclic antidepressants (TCA), Methadone (MTD), and Ecstasy (MDMA)
This variety allows drug testing facilities to provide a comprehensive assessment in a single process, improving both efficiency and accuracy.
Why Are These Substances Included?
The substances detected by the 17 panel drug test were carefully chosen to address the growing challenges faced by industries that require drug screening. Many of these drugs are commonly abused either recreationally or medically, presenting risks to safety, productivity, and legal compliance.
For instance, substances like fentanyl and oxycodone are heavily abused opioids that can lead to workplace impairment. EtG and THC are also included due to their widespread misuse. Others, like KRA and TCA, represent emerging drug trends that are increasingly important to monitor.
Reviews
There are no reviews yet.